CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Providing of Topical Products

PlusCBD™ Oil Roll-On establish at 945 Kroger shops in 17 U.S. States

LAS VEGAS, NEVADA, June 12, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a supplier that is preeminent maker of hemp CBD items, is happy to announce further expansion of its industry-dominating PlusCBD™ Oil brand name utilizing the Kroger Co. (NYSE:KR).

The Company’s expanded distribution that is retail the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across nearly all its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths places in 17 U.S. states. PlusCBD™ Oil Roll-On, available in 200mg CBD and further Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant parts, warming camphor and menthol that is cooling. Fashioned with its Gold Formula focused complete range hemp extract, the Roll-Ons offer high strength help in a application that is easy-to-use. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms can also be found at the participating Kroger places. To generally meet customer objectives of clean components, all PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and they are made without artificial dyes or scents.

As talked about regarding the Company’s first quarter 2019 profits turn to May 8, 2019, CV Sciences’ recent circulation gains consist of accessibility to PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy shops. By the addition of 945 Kroger areas and brand new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are obtainable in 4,591 stores, up from 3,308 shops at the time of March 31, 2019, a rise of 38.7% on the previous 2 months.

“We are happy to partner with Kroger and introduce our brand new Roll-On topical as we carry on our fast expansion to the FDM channel,” said Joseph Dowling, ceo. “Kroger, CVS Pharmacy, and other leading national retailers are keenly alert to the increased customer need for hemp-based CBD items and they’re partnering with CV Sciences as a result of our commitment that is unwavering to and quality. Our company is at the beginning of that which we think would be acceptance that is broad of products across national FDM records so we enjoy our continued growth once we increase shop count and SKUs with your retail lovers.”

PlusCBD™ Oil cbd oil Extra Strength Balm ranks #1 in product product sales both in the Total U.S. Natural Channel and complete U.S. MULO (Multi Outlet) during the last 52 days* among CBD services and services and products within Topical Analgesics, relating to SPINS and IRI information, correspondingly. Brightfield Group, a number one predictive analytics and researching the market company for the CBD market, expects $1.3 billion in product product sales of CBD topicals in 2019, by having an ingredient growth that is annual of 169% from 2018 – 2022.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) operates two business that is distinct: a consumer item unit centered on production, advertising and attempting to sell plant-based CBD items to a selection of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil could be the top-selling make of hemp-derived CBD available on the market, according to SPINS, the key provider of syndicated information and insights when it comes to normal, organic and specialty items industry. CV Sciences, Inc. has offices that are primary facilities in north park, Ca and vegas, Nevada. Extra information can be obtained from OTCMarkets.com or by visiting www.cvsciences.com.

This pr release may include specific forward-looking statements and information, as defined inside the concept of Section 27A of this Securities Act of 1933 and Section 21E associated with the Securities Exchange Act of 1934, and it is at the mercy of the secure Harbor produced by those parts. This product contains statements about anticipated events that are future economic results which are forward-looking in nature and at the mercy of risks and uncertainties. Such statements that are forward-looking meaning incorporate dangers, uncertainties.